³Ô¹ÏÍøÕ¾

Latest

Latest AusBiotech News | Page 3

  • Latest AusBiotech news stories and updates. What is happening today? All recent AusBiotech news and developments. Live coverage and timeline of AusBiotech. All you need to know about AusBiotech.
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
Dimerix says the recruitment of adolescent patients to commence in Phase 3 trial
Top Performing ASX Companies
BioMelbourne Network board strengthened with five new appointments
Actinogen’s phase 2a depression trial completes final patient visit
First CEO for the Sydney-based Viral Vector Manufacturing Facility
Actinogen Medical says positive Xanamem phase 2a biomarker trial published in key Journal
Immutep reports topline results from TACTI-003 Phase 2b trial
Funding available for dementia and cognitive decline innovations through CUREator+
Members Sought For New Policy Taskforce
Imugene doses the first patient in pioneering Phase 1 onCARlytics tria
Immutep signs exclusive license agreement with Cardiff University for anti-LAG-3 molecules
State Government Budget Wrap For Life Sciences
Merck Life Science opens applications for 2024 ANZ Advance Biotech Grant Program
QUT Joins Artificial Heart Frontiers Program Consortium
Registrations open for Australia’s ‘biggest week in biotech’
Opthea completes placement and institutional component of entitlement offer
US FDA grants rare paediatric disease designation to Race Oncology’s RC220 bisantrene
New Grant Programme For Quantum Technologies
Race says bisantrene highly active in a mouse model of multiple myeloma
Cervical cancer screening pioneer among biotech sector’s King’s Birthday recipients
Fifth patient is treated with the OncoSil device in PANCOSIL trial
MCRI and Incepta Pharmaceuticals partner to protect children from rotavirus Murdoch Children’s Research Institute and Bangladesh-based Incepta Pharmaceuticals have announced a co
Member views sought on TGA’s companion diagnostic guidance update
Genomic profiling PrOSPeCT achieves a significant patient milestone
AusBiotech and BIO partner to deliver ‘Investing in Australia’ Roundtable at BIO 2024
World Intellectual Property Organization (WIPO) approves landmark treaty on IP and genetic resources
Immutep announces major capital raise and third collaboration with MSD
AusBiotech supports Team Australia delegation at BIO 2024
Best Translational Research Awarded At AusMedtech 2024
Neuren says trial shows significant improvements in Pitt Hopkins syndrome
Dimerix announces Middle East license agreement for DMX-200
Telix completes proof-of-concept study of TLX592 in prostate cancer
AusMedtech 2024 Underway In Adelaide
New centre to bring more international eye clinical trials to Victoria
AdAlta appoints Melbourne-based Cell Therapies as preferred manufacturing partner
PYC Therapeutics plans to progress candidate to human clinical trials
Launch of new Queensland-based research and manufacturing hub targeting precision medicines
Novartis, Monash University and Monash Health partner for heart
Cell & Gene Catalyst champions industry at BioKorea 2024
CUREator deploys $7.21 Million to propel local life sciences potential
PolyNovo announces appointment of general counsel and company secretary
TGA Seeks Applicants For Statutory Advisory Committees
Industry applauds $18.8m funding for ³Ô¹ÏÍøÕ¾ One Stop Shop for clinical trials
Mesoblast Announces Appointment Of New Board Chair
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
AusMedtechInvest Keynote And Panel Speakers Announced

© 2024 - ³Ô¹ÏÍøÕ¾